Loading…

p -Cymene Complexes of Ruthenium(II) as Antitumor Agents

In this work, the cytotoxic behavior of six ruthenium(II) complexes of stoichiometry [(η - -cymene)RuCl L] (I-VI), L = 4-cyanopyridine (I), 2-aminophenol (II), 4-aminophenol (III), pyridazine (IV), and [( - -cymene)RuClL ]PF ; L = cyanopyridine (V), L = 2-aminophenol(VI) towards three cell lines was...

Full description

Saved in:
Bibliographic Details
Published in:Molecules (Basel, Switzerland) Switzerland), 2020-10, Vol.25 (21), p.5063
Main Authors: Pujante-Galián, María Angeles, Pérez, Sergio A, Montalbán, Mercedes G, Carissimi, Guzmán, Fuster, Marta G, Víllora, Gloria, García, Gabriel
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:In this work, the cytotoxic behavior of six ruthenium(II) complexes of stoichiometry [(η - -cymene)RuCl L] (I-VI), L = 4-cyanopyridine (I), 2-aminophenol (II), 4-aminophenol (III), pyridazine (IV), and [( - -cymene)RuClL ]PF ; L = cyanopyridine (V), L = 2-aminophenol(VI) towards three cell lines was studied. Two of them, HeLa and MCF-7, are human carcinogenic cells from cervical carcinoma and human breast cancer, respectively. A comparison with healthy cells was carried out with BGM cells which are monkey epithelial cells of renal origin. The behavior of complex II exhibits selectivity towards healthy cells, which is a promising feature for use in cancer treatment since it might reduce the side effects of most current therapies.
ISSN:1420-3049
1420-3049
DOI:10.3390/molecules25215063